Review Article

Benign Smooth Muscle Tumors (Leiomyomas) of Deep Somatic Soft Tissue

Table 1

Summary of case series reporting the clinicopathological features of leiomyomas of deep somatic soft tissue.

Authors; year of publication
Billings et al.; 2001 [10]Kilpatrick et al.; 1994 [9]

Clinical feature
 AgeMiddle-aged adults (median, 44 years; range, 12–55 years)Median, 35 years; range 14–62 years
 GenderM = FM = F
 Anatomical siteDeep somatic soft tissue of the lower extremity, upper extremity, trunk, axilla, and backExtremities was the most common site

Histological feature
 ArchitectureWell-marginated; fascicular architectureWell-defined circumscription; fascicular architecture
 Lesional cellsMature-appearing smooth muscle cells with abundant eosinophilic cytoplasmSpindle cells with mostly uniform, round-ended, elongated nuclei, and tapering eosinophilic cytoplasm
 Nuclear atypiaAbsent; minimal atypia of a focal nature acceptableAbsent
 Mitotic countAbsent or very low (≤4 mitoses/50 HPF and ≤1 mitosis/50 HPF in the majority)≤1 mitosis/50 HPF
 Atypical mitotic figuresAbsentNot described
 Coagulative tumor necrosisAbsentAbsent
 Other findingsStromal hyalinization (majority of cases); prominent stromal calcification (some cases); degenerative nuclear changesDystrophic calcification (some cases); degenerative nuclear changes (some cases)

IHC
 ER and PRNegativeNot described

Authors’ conclusionSMTs of somatic soft tissue that lack atypia, necrosis, and mitotic activity can with reasonable confidence be labeled leiomyomasThe presence of any mitoses in SMTs of subcutaneous or deep soft tissue should be regarded as indicative of potential malignancy; WLE and careful F/U advised

M, male; F, female; HPF, high power fields; IHC, immunohistochemistry; ER, estrogen receptor protein; PR, progesterone receptor protein; SMTs, smooth muscle tumors; WLE, wide local excision; F/U, follow-up. The authors concluded that a smooth muscle tumor of somatic soft tissue with 1–5 mitoses/50 HPF should be regarded as “leiomyoma of uncertain malignant potential.”